Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function
Open Access
- 1 October 2019
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 10 (1) , 1-15
Abstract
TCR-gene-transfer is an efficient strategy to produce therapeutic T cells of defined antigen specificity. However, there are substantial variations in the cell surface expression levels of human TCRs, which can impair the function of engineered T cells. Here we demonstrate that substitutions of 3 amino acid residues in the framework of the TCR variable domains consistently increase the expression of human TCRs on the surface of engineered T cells.The modified TCRs mediate enhanced T cell proliferation, cytokine production and cytotoxicity, while reducing the peptide concentration required for triggering effector function up to 3000-fold. Adoptive transfer experiments in mice show that modified TCRs control tumor growth more efficiently than wild-type TCRs. Our data indicate that simple variable domain modifications at a distance from the antigen-binding loops lead to increased TCR expression and improved effector function. This finding provides a generic platform to optimize the efficacy of TCR gene therapy in humans.Keywords
This publication has 40 references indexed in Scilit:
- Organization of the resting TCR in nanoscale oligomersImmunological Reviews, 2012
- Unbiased Molecular Analysis of T Cell Receptor Expression Using Template‐Switch Anchored RT‐PCRCurrent Protocols in Immunology, 2011
- Overview of theCCP4 suite and current developmentsActa Crystallographica Section D Structural Biology, 2011
- A highly tilted binding mode by a self-reactive T cell receptor results in altered engagement of peptide and MHCJournal of Experimental Medicine, 2011
- Mechanisms for T cell receptor triggeringNature Reviews Immunology, 2010
- Mixed T cell receptor dimers harbor potentially harmful neoreactivityProceedings of the National Academy of Sciences, 2010
- Cancer Regression in Patients After Transfer of Genetically Engineered LymphocytesScience, 2006
- Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide‐MHC without increasing apparent cross‐reactivityProtein Science, 2006
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004
- Serial triggering of many T-cell receptors by a few peptide–MHC complexesNature, 1995